The Effect of Motivational Interviewing on Self-Efficacy and Quality of Life in Gestational Diabetes Mellitus

September 25, 2025 updated by: Meltem Akbaş, Cukurova University

The Effect of Motivational Interviewing on Health Management Self-Efficacy and Quality of Life in Pregnants With Gestational Diabetes Mellitus

This study is a randomized controlled experimental study planned to investigate the effect of motivational interviewing on health management self-efficacy and quality of life in pregnant women with gestational diabetes mellitus.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study is a randomized controlled experimental study planned to investigate the effect of motivational interviewing on health management self-efficacy and quality of life in pregnant women with gestational diabetes mellitus. 24-26 weeks for pregnant women diagnosed with gestational diabetes mellitus. A total of motivational interviews will be held for 4 weeks with the pregnant women. Personal Information Form, Health Management Self-Efficacy Scale and Quality of Life Scale will be administered before the motivational interview, and the Health Management Self-Efficacy Scale and Quality of Life Scale will be administered at the end of the motivational interview.

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Sarıçam
      • Adana, Sarıçam, Turkey (Türkiye), 01330
        • Meltem Akbaş

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Being pregnant for the first time

  • Being diagnosed with gestational diabetes mellitus
  • 24-28. Being in the pregnancy week
  • Being able to speak and understand Turkish
  • Being 18 years or older
  • Having a single and viable fetus
  • Volunteering to participate in research
  • Having and being able to use a mobile phone
  • Having all check-ups at the same hospital and regularly throughout pregnancy,

Exclusion Criteria:

  • Being diagnosed with diabetes mellitus (type 1, type 2 diabetes) before pregnancy
  • Having a psychiatric diagnosis,
  • Having a chronic disease
  • Having risk factors such as threat of premature birth, placenta previa, premature rupture of membranes
  • Having any disability that would prevent communication (deafness, hearing impairment, etc., use of languages other than Turkish),
  • Pregnant women who do not want to continue the study and give birth before the 37th week of pregnancy will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Education
24-26 weeks for pregnant women diagnosed with gestational diabetes mellitus. A total of motivational interviews will be held for 4 weeks with the pregnant women. Personal Information Form, Health Management Self-Efficacy Scale and Quality of Life Scale will be administered before the motivational interview, and the Health Management Self-Efficacy Scale and Quality of Life Scale will be administered at the end of the motivational interview.
Behavioral: Motivational Interview to Increase Health Management Self-Efficacy and Quality of Life in Pregnant Women Diagnosed with Gestational Diabetes Mellitus
Motivational interviewing is a client-centered approach used to elicit behavioral change by helping clients explore and resolve their ambivalence.
No Intervention: Control
24-26 weeks for pregnant women diagnosed with gestational diabetes mellitus. Personal Information Form, Health Management Self-Efficacy Scale and Quality of Life Scale will be applied to the pregnant patient.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-Efficacy Scale in Health Management
Time Frame: As the score obtained from the scale increases, self-efficacy for health practices increases.
Before and after training between the 24th and 26th weeks of pregnancy
As the score obtained from the scale increases, self-efficacy for health practices increases.
Quality of Life Scale
Time Frame: As the total score decreases, the quality of life decreases.
Before and after training between the 24th and 26th weeks of pregnancy
As the total score decreases, the quality of life decreases.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cukurova University

Investigators

  • Principal Investigator: Meltem Akbaş, PhD, Universty Of Cukurova

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2023

Primary Completion (Actual)

January 30, 2025

Study Completion (Actual)

September 20, 2025

Study Registration Dates

First Submitted

November 15, 2023

First Submitted That Met QC Criteria

February 5, 2024

First Posted (Actual)

February 6, 2024

Study Record Updates

Last Update Posted (Estimated)

September 30, 2025

Last Update Submitted That Met QC Criteria

September 25, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 02.06.2023/134

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe